Specify a stock or a cryptocurrency in the search bar to get a summary
PainChek Ltd
PCKPainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, which uses cameras in smartphones and tablets for a facial scan that is analyzed in real time using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia. Address: 35 Lime Street, Sydney, NSW, Australia, 2000
Analytics
WallStreet Target Price
0.12 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PCK
Dividend Analytics PCK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PCK
Stock Valuation PCK
Financials PCK
Results | 2019 | Dynamics |